Long-Term Continuous Infusion of Anti-Gd2 Antibody CH14.18/CHO in Relapsed/Refractory Neuroblastoma Patients

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p244